• Wed, March 3, 2021

by: WOPRAI

James Faucette Maintained (TTEC) at Hold with Increased Target to $87 on, Mar 3rd, 2021

by: WOPRAI

Jed Dorsheimer Maintained (AMRC) at Strong Buy with Increased Target to $82 on, Mar 3rd, 2021

by: WOPRAI

Damian Karas Maintained (AOS) at Hold with Increased Target to $62 on, Mar 3rd, 2021

by: WOPRAI

Luke Sergott Initiated (TMO) at Buy and Held Target at $525 on, Mar 3rd, 2021

by: WOPRAI

Peter Benedict Maintained (TGT) at Buy with Decreased Target to $200 on, Mar 3rd, 2021

by: WOPRAI

Mark Astrachan Maintained (TGT) at Strong Buy with Decreased Target to $220 on, Mar 3rd, 2021

by: WOPRAI

Michael Baker Maintained (TGT) at Strong Buy with Decreased Target to $210 on, Mar 3rd, 2021

by: WOPRAI

Stephanie Wissink Maintained (TGT) at Hold with Decreased Target to $188 on, Mar 3rd, 2021

by: WOPRAI

Kelly Bania Maintained (TGT) at Buy with Increased Target to $205 on, Mar 3rd, 2021

by: WOPRAI

Michael Lasser Maintained (TGT) at Hold with Decreased Target to $185 on, Mar 3rd, 2021

by: WOPRAI

Kate McShane Maintained (TGT) at Strong Buy with Decreased Target to $212 on, Mar 3rd, 2021

by: WOPRAI

Joshua Wilson Maintained (TGLS) at Buy with Increased Target to $10 on, Mar 3rd, 2021

by: WOPRAI

Devin Ryan Initiated (TCPC) at Buy and Held Target at $15 on, Mar 3rd, 2021

by: WOPRAI

Jack Meehan Initiated (AVTR) at Buy and Held Target at $33 on, Mar 3rd, 2021

by: WOPRAI

Robert Dodd Maintained (WHF) at Buy with Increased Target to $16 on, Mar 3rd, 2021

by: WOPRAI

Andrew Wittmann Upgraded (WSC) to Buy and Increased Target to $33 on, Mar 3rd, 2021

by: WOPRAI

Emily Chieng Upgraded (AA) to Strong Buy and Increased Target to $32 on, Mar 3rd, 2021

by: WOPRAI

Tyler Radke Initiated (ADBE) at Hold and Held Target at $523 on, Mar 3rd, 2021

by: WOPRAI

Salveen Richter Downgraded (ADPT) to Hold and Decreased Target to $63 on, Mar 3rd, 2021

by: WOPRAI

Brent Bracelin Maintained (VEEV) at Buy with Increased Target to $350 on, Mar 3rd, 2021

by: WOPRAI

Ryan MacDonald Maintained (VEEV) at Strong Buy with Increased Target to $336 on, Mar 3rd, 2021

by: WOPRAI

Stephanie Davis Maintained (VEEV) at Hold with Increased Target to $294 on, Mar 3rd, 2021

by: WOPRAI

Stan Zlotsky Maintained (VEEV) at Buy with Increased Target to $340 on, Mar 3rd, 2021

by: WOPRAI

Jerry Revich Maintained (URI) at Strong Buy with Increased Target to $330 on, Mar 3rd, 2021

by: WOPRAI

Patrick Hummel Maintained (TSLA) at Hold with Increased Target to $730 on, Mar 3rd, 2021

by: WOPRAI

Zachary Fadem Maintained (TSCO) at Buy with Increased Target to $180 on, Mar 3rd, 2021

by: WOPRAI

Ronald Epstein Maintained (SPCE) at Strong Buy on, Mar 3rd, 2021

by: WOPRAI

Paul Fremont Downgraded (BKH) to Hold and Decreased Target to $60 on, Mar 3rd, 2021

by: WOPRAI

Billy Kovanis Maintained (CAR) at Buy with Increased Target to $61 on, Mar 3rd, 2021

by: WOPRAI

Jerry Revich Maintained (CAT) at Strong Buy with Increased Target to $240 on, Mar 3rd, 2021

by: WOPRAI

Ricky Goldwasser Maintained (CAH) at Hold with Decreased Target to $64 on, Mar 3rd, 2021

by: WOPRAI

George Tong Initiated (BCO) at Strong Buy and Held Target at $92 on, Mar 3rd, 2021

by: WOPRAI

Umer Raffat Initiated (VOR) at Buy and Held Target at $48 on, Mar 3rd, 2021

by: WOPRAI

Carter Gould Initiated (VOR) at Buy and Held Target at $56 on, Mar 3rd, 2021

by: WOPRAI

Naved Khan Maintained (ABNB) at Hold with Increased Target to $180 on, Mar 3rd, 2021

by: WOPRAI

Richard Hill Maintained (AMH) at Hold with Increased Target to $33 on, Mar 3rd, 2021

by: WOPRAI

Quinn Bolton Maintained (AMBA) at Strong Buy with Increased Target to $140 on, Mar 3rd, 2021

by: WOPRAI

Joseph Moore Maintained (AMBA) at Buy with Increased Target to $137 on, Mar 3rd, 2021

by: WOPRAI

Tore Svanberg Maintained (AMBA) at Strong Buy with Increased Target to $135 on, Mar 3rd, 2021

by: WOPRAI

Suji Desilva Maintained (AMBA) at Strong Buy with Increased Target to $150 on, Mar 3rd, 2021

by: WOPRAI

Richard Shannon Maintained (AMBA) at Strong Buy with Increased Target to $150 on, Mar 3rd, 2021

by: WOPRAI

Samik Chatterjee Upgraded (ST) to Buy and Increased Target to $72 on, Mar 3rd, 2021

  • Thu, March 4, 2021

by: WOPRAI

Kimberly Greenberger Maintained (URBN) at Buy with Increased Target to $37 on, Mar 4th, 2021

by: WOPRAI

Eric Wold Initiated (AOUT) at Strong Buy and Held Target at $32 on, Mar 4th, 2021

by: WOPRAI

Kimberly Greenberger Maintained (ANF) at Sell with Increased Target to $22 on, Mar 4th, 2021

by: WOPRAI

Nick Setyan Maintained (WEN) at Buy with Decreased Target to $27 on, Mar 4th, 2021

by: WOPRAI

Ken Hoexter Upgraded (WERN) to Strong Buy and Increased Target to $52 on, Mar 4th, 2021

by: WOPRAI

Neil Kalton Upgraded (WEC) to Buy and Decreased Target to $93 on, Mar 4th, 2021

Salveen Richter Downgraded (ADPT) to Hold and Decreased Target to $63 on, Mar 3rd, 2021

Salveen Richter of Goldman Sachs, Downgraded "Adaptive Biotechnologies Corporation" (ADPT) to Hold and Decreased Target from $74 to $63 on, Mar 3rd, 2021.

Salveen has made no other calls on ADPT in the last 4 months.



There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, all agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Increased Target to $60 on, Friday, February 26th, 2021

Like: 👍